Patent · US Active

Presbyopia treatments

US11285134B2 · kind B2 · utility

3Cited by

44References

36Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Michael R. Robinson · Irvine, US
Mohammed I. Dibas · Laguna Niguel, US
Jaya Giyanani · Irvine, US
Anuradha V. Gore · Aliso Viejo, US
Sungwook Lee · Orange, US
Haixia Liu · Shanghai, CN
Aileen Morgan · Rancho Santa Margarita, US
Jihao Zhou · Rancho Santa Margarita, US

Key dates

Filing date	Feb 14, 2020
Grant date	Mar 29, 2022
Priority date	—
Expiry date	Feb 14, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/186
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.